As of August 28, 2026, Erasca, Inc. (ERAS) has a DilutionWatch DilutionScore of 39/100, rated MEDIUM dilution risk. Erasca, Inc. has a market capitalization of $3.99B, 349.76M shares outstanding, 226 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $200.00M.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 16%
💰 Capital Raise
model 33%
• Under 12 months cash (10mo)
• Active ATM program with $200M remaining capacity
Market Data
Market Cap$3.99B
Shares Outstanding349.76M
Float207.89M
Cash$96.53M
Debt$45.95M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 36.7% shares (2026Q1 vs prior)
226 institutional holders · 312.71M shares
#1
Frazier Life Sciences Management, L.P.
24.68M shares
#2
Vivo Capital, LLC
24.30M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
22.50M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest29.95M
Days to Cover7.3
% of Float14.4%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2021-12-31
4
INSIDER TRANSACTION
2026-04-03
4
INSIDER TRANSACTION
2026-03-06
4
INSIDER TRANSACTION
2026-01-30
4
INSIDER TRANSACTION
2026-01-30
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual ERAS Dilution Snapshot
Erasca, Inc. (ERAS) has a DilutionScore of 39/100, rated Medium dilution risk. Score date: August 28, 2026.
- Stored ATM program remaining capacity: $200.0M.
- Recent SEC activity tracked for ERAS: 4 on 2026-04-03; 4 on 2026-03-06; 4 on 2026-01-30.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track ERAS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ERAS — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for ERAS
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.